Fos is a preferential target of glucocorticoid receptor inhibition of AP-1 activity in vitro. |
| |
Authors: | T K Kerppola D Luk and T Curran |
| |
Institution: | Department of Molecular Oncology and Virology, Roche Institute of Molecular Biology, Nutley, New Jersey 07110. |
| |
Abstract: | |
| |
Keywords: | |
|
|